Tiziana Life Sciences is trading at $1.03 (+6.38%) after a technical rebound from recent volatility and broader strength in the biotech sector.
- The move aligns with a risk-on market backdrop and a 2.02% gain in the XBI biotech ETF.
- Recent price action is characterized as a bounce from a prior selloff that lacked fresh news or a fundamental re-rating, supporting a technical recovery rather than a structural shift.